Protinhi Therapeutis secures €1.7mln Eurostars subsidy

Venture Challenge alumnus Protinhi Therapeutics was awarded the most innovative Eurostars project in The Netherlands in 2022. The €1.7mln Eurostars subsidy was awarded to a consortium of Protinhi Therapeutics, Sciomics GmbH and Artemis Bio-Support to develop effective diagnostic-prognostic tools and bread-spectrum antiviral drugs agains coronaviruses with the aim to enable patient stratification and early treatment to diminish the devastating effects of long-COVID.

Read more on LinkedIn



‹ News overview